1. Ampudia-Mesias, Elisabet, El-Hadad, Samia, Cameron, Charles Scott, Saydam, Nurten, Saydam, Okay. 2022. SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma. In Cancers, 14, . doi:10.3390/cancers14081984. https://pubmed.ncbi.nlm.nih.gov/35454889/
2. Chen, Hao, Pan, Yuhao, Lv, Chenhui, Wu, Dingting, Xuan, Qijia. 2024. Telomere-related gene risk model for prognosis prediction in colorectal cancer. In Translational cancer research, 13, 3495-3521. doi:10.21037/tcr-24-43. https://pubmed.ncbi.nlm.nih.gov/39145075/
3. Liu, Chao Lien, Pan, Hung Wei, Torng, Pao Ling, Fan, Ming Huei, Mao, Tsui Lien. 2019. SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma. In Oncology reports, 42, 2706-2715. doi:10.3892/or.2019.7379. https://pubmed.ncbi.nlm.nih.gov/31638245/
4. Wei, Bajin, Xiao, Shuyuan, Lou, Weiyang. 2023. In silico whole-transcriptome analysis reveals a potential hsa_circ_0000375-miR-424-5p-TPM2/SRPX/SRGAP1 regulatory network related to liver metastasis of colorectal cancer. In Heliyon, 9, e21688. doi:10.1016/j.heliyon.2023.e21688. https://pubmed.ncbi.nlm.nih.gov/37954397/
5. Liu, Xingchen, Pan, Bo, Ding, Jie, Hong, Jing, Zheng, Jianming. 2025. Identifying potential signatures of immune cells in hepatocellular carcinoma using integrative bioinformatics approaches and machine-learning strategies. In Immunologic research, 73, 46. doi:10.1007/s12026-024-09585-3. https://pubmed.ncbi.nlm.nih.gov/39904830/